One of the most significant limitations is the relatively small number of patients recruited, which likely contributed to some results trending toward significance but not reaching it.
← all excerpts
Coronary flow reserve increase after 4-year dapagliflozin treatment in patients with type 2 diabetes: the DAPAHEART follow-up study.
1
—
—